Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aiwen Yan
Docosahexaenoic Acid Serving as Sensitizing Agents and Gefitinib Resistance Revertants in EGFR Targeting Treatment
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Omega-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy
Docosahexaenoic Acid Monoglyceride Increases Carboplatin Activity in Lung Cancer Models by Targeting EGFR
Anticancer Research
Medicine
Cancer Research
Oncology
Epigenetic Silencing of miR-483-3p Promotes Acquired Gefitinib Resistance and EMT in EGFR-mutant NSCLC by Targeting Integrin Β3
Oncogene
Cancer Research
Genetics
Molecular Biology
Author Correction: Targeting Hsp90 With FS-108 Circumvents Gefitinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer Cells
Acta Pharmacologica Sinica
Medicine
Pharmacology
Brief Report: Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer With Sensitizing EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Allosterically Targeting EGFR Drug-Resistance Gatekeeper Mutations
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Linc01014 Regulates Gefitinib Resistance in Oesophagus Cancer via EGFR‐PI3K‐AKT‐mTOR Signalling Pathway
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Insulin Sensitizing Agents and Polycystic Ovary Syndrome
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Targeting Autophagy for Overcoming Resistance to Anti-Egfr Treatments
Cancers
Cancer Research
Oncology
